Alvaro Moreno-Aspitia

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Top Venues

Breast cancer research and treatment

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Mathew Amprayil Cherian, Ahmed M Elkhanany, Ciara Catherine O'Sullivan, Alvaro Moreno-Aspitia, Paul Plourde, Lyon L Gleich, Kendra Riesen, Ross Ezzati, Meghan Degele, Megan Shulman, Stephanie Dobson Stempf, Laura Sachse, Amrita A Iyer, Senthil Damodaran, Matthew M Cooney
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model. JCO clinical cancer informatics 7 (2023)
Diogo Martins-Branco, Marie Kassapian, Veronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni, Charitini Andriakopoulou, Sarra El-Abed, Susan L Ellard, Miguel Izquierdo, Malou Vicente, Saranya Chumsri, Martine J Piccart, Alvaro Moreno-Aspitia, Ann Søegaard Knop, Janine Lombard, Evandro de Azambuja
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study. Breast cancer research and treatment (2023)
Roberto A Leon-Ferre, Edith A Perez, David W Hillman, Celyne Bueno, Alejandra T Perez, Beiyun Chen, Robert B Jenkins, Donald W Northfelt, David B Johnson, Robert L Carolla, Robin T Zon, Alvaro Moreno-Aspitia
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer. Breast cancer research and treatment 182 (3) (2020)